Has Josephine Samson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $780 in general payments to Josephine Samson, MD across 31 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Josephine Samson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Josephine Samson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Josephine Samson, MD

Pulmonary Disease · New York, NYNPI 1174528137

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.9% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by AstraZeneca at 28.3% of the total. Reporting peaked in 2019 at $391 and has fallen 65.9% since, to $133 in 2023. That places this record below the midpoint for pulmonary disease clinicians in NY, where the typical reported total is $756.

$780in general payments, 2019–2025

Across 31 payments — averaging $25.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$220
Insmed, Inc.$140
Inspire Medical Systems, Inc.$133
Amgen$80
GSK$77
Genentech USA, Inc.$42
plus $87 from 4 others

What the payments were for

Food & beverage$76498%
Education$162%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	6	$220
Insmed, Inc.	8	$140
Inspire Medical Systems, Inc.	1	$133
Amgen	4	$80
GSK	6	$77
Genentech USA, Inc.	2	$42
Boehringer Ingelheim	1	$29
Johnson & Johnson	1	$29
Advanced Respiratory, Inc	1	$16
Circassia Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$780 in reported general payments places this provider in the 50th percentile of 1,115 pulmonary disease providers in New York.

See all pulmonary disease providers in New York →

Medicare billing

Part B allowed, 2024

$56,673

Medicare patients

Services billed

619

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Fluticasone-SalmeterolFluticasone Propion/Salmeterol	33	$2,028
Wixela InhubFluticasone Propion/Salmeterol	23	$1,200
Telmisartan	30	$707
Enalapril Maleate	46	$598
Rosuvastatin Calcium	89	$574
Albuterol Sulfate HfaAlbuterol Sulfate	27	$473
Atorvastatin Calcium	57	$429
Amlodipine Besylate	49	$221
Metoprolol Succinate	21	$175
Candesartan Cilexetil	17	$164
Simvastatin	27	$139
Allopurinol	12	$137
Ezetimibe	11	$110
Losartan Potassium	13	$96
Azithromycin	32	$76

Paid to pharmacies, not to this prescriber.

Other pulmonary disease in New York

Charles PowellNew York$654K
Bisher AkilNew York$480K
Sonali SethiNew York$388K
Johnathan RaskinNew York$338K
Monica KraftNew York$247K
Jamie BessichNew York$226K
Ronald CrystalNew York$213K
Michael NiedermanNew York$176K
Wilfredo TalaveraNew York$145K
Josanna Rodriguez-LopezNew York$128K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →